SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-20-253525
Filing Date
2020-09-24
Accepted
2020-09-24 17:26:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d11782dsc14d9a.htm SC 14D9/A 29347
2 EX-99.(A)(5)(E) d11782dex99a5e.htm EX-99.(A)(5)(E) 75246
3 GRAPHIC g11782dsp003.jpg GRAPHIC 9245
4 GRAPHIC g11782dsp037.jpg GRAPHIC 149221
  Complete submission text file 0001193125-20-253525.txt   324690
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filed by) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Subject) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-90051 | Film No.: 201196120
SIC: 2834 Pharmaceutical Preparations